Metabolic Syndrome Screening and Assertive Community Treatment: A Quality Improvement Study

Area of Science:

• Public Health
• Cardiology
• Psychiatry

Background:

• Metabolic syndrome is prevalent in individuals with serious mental illness (SMI), posing significant risks for poor physical health and mortality.
• Despite guidelines, physical health screenings, including for metabolic syndrome, are often lacking for individuals with SMI.
• Assertive Community Treatment (ACT) teams serve individuals with SMI, presenting an opportunity for integrated health screening.

Purpose of the Study:

• To implement and evaluate a quality improvement (QI) project aimed at increasing metabolic syndrome screening rates within NYC ACT teams.
• To assess the prevalence of metabolic syndrome and its components (hypertension, diabetes, dyslipidemia) in an ACT population.

Main Methods:

• A QI project was conducted from December 2010 to May 2011 across three NYC ACT teams.
• Interventions included educational sessions for staff and consumers and the implementation of a systematic screening protocol.
• Complete metabolic syndrome screening measurements were collected for 71% of eligible ACT consumers.

Main Results:

• Metabolic risk was nearly universal among the screened ACT consumers.
• Over half of the participants were diagnosed with metabolic syndrome.
• High rates of previously undiagnosed hypertension, diabetes, and dyslipidemia were identified.

Conclusions:

• Systematic metabolic syndrome screening is feasible within ACT settings and can be integrated into routine care.
• ACT teams can play a crucial role in addressing physical health disparities in individuals with SMI.
• Findings support policy initiatives for better integration of behavioral health and primary care services.